Relay Therapeutics (RLAY) Revenue (2021 - 2026)
Relay Therapeutics' (RLAY) quarterly Revenue came in at $3.0 million in Q1 2026, down 60.93% year-on-year from $7.7 million in Q1 2025, and down 57.14% on a QoQ basis from $7.0 million in Q4 2025.
Relay Therapeutics (RLAY) Revenue (2021 - 2026) Analysis & Trends
Relay Therapeutics (RLAY) has 6 years of Revenue data on file, last reported at $3.0 million in Q1 2026.
- On a quarterly basis, Revenue fell 60.93% year-over-year to $3.0 million in Q1 2026; TTM through Mar 2026 was $10.7 million, a 39.04% increase from a year earlier, with the FY2025 full-year figure at $15.4 million, up 53.44% from the prior year.
- Revenue for Q1 2026 stood at $3.0 million, down from $7.0 million in the prior quarter.
- Over the last five years, Revenue for RLAY reached as high as $25.2 million in Q3 2023 and fell as low as -$1000.0 in Q4 2023.
- Historically, Revenue has averaged $4.3 million across 5 years, with a median of $419000.0 in 2022.
- On a YoY basis, Revenue climbed as much as 7226.16% in 2023 and fell as far as 100.4% in 2023.
- Year by year, Revenue stood at $253000.0 in 2022, then slumped by 100.4% to -$1000.0 in 2023, then surged by 1000800.0% to $10.0 million in 2024, then plunged by 30.05% to $7.0 million in 2025, then sank by 57.14% to $3.0 million in 2026.
- Per Business Quant data, the three most recent Revenue figures were $3.0 million in Q1 2026, $7.0 million in Q4 2025, and $677000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.51 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.99 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 3.61 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 1.30 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Relay Therapeutics | 3.31 Bn | 3.31 Bn | - | 3.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.00 Mn |
| Dec 31, 2025 | 7.00 Mn |
| Jun 30, 2025 | 677,000.00 |
| Mar 31, 2025 | 7.68 Mn |
| Mar 31, 2024 | 10.01 Mn |
| Dec 31, 2023 | -1,000.00 |
| Sep 30, 2023 | 25.20 Mn |
| Jun 30, 2023 | 119,000.00 |
| Mar 31, 2023 | 226,000.00 |
| Dec 31, 2022 | 253,000.00 |
| Sep 30, 2022 | 344,000.00 |
| Jun 30, 2022 | 365,000.00 |
| Mar 31, 2022 | 419,000.00 |
| Dec 31, 2021 | 567,000.00 |
| Sep 30, 2021 | 666,000.00 |
| Jun 30, 2021 | 844,000.00 |
| Mar 31, 2021 | 952,000.00 |